$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
妊娠期间使用吉三代进行丙肝抗病毒治疗预防母婴传播的六大原因
2025-10-19 11:44:20
Check Details
口服DAA药物为丙肝患者带来新希望
2025-10-19 11:44:20
Check Details
丙肝预防,早期筛查、早发现、早治疗
2025-10-19 11:44:20
Check Details
丙肝患者服用吉二代前注意事项
2025-10-19 11:44:20
Check Details
丙肝合并其他疾病患者服用DAA药物须谨慎
2025-10-19 11:44:20
Check Details
丙肝治疗,选药是关键
2025-10-19 11:44:20
Check Details
在中国,丙肝的治疗面临的挑战
2025-10-19 11:44:20
Check Details
直接抗病毒药物治疗后不良事件可持续数月
2025-10-19 11:44:20
Check Details
丙肝防治要做到及早筛查
2025-10-19 11:44:20
Check Details
为什么基因4型丙肝患者抗病毒治疗可能失败
2025-10-19 11:44:20
Check Details
丙通沙(吉三代)治疗丙肝的优势?
2025-10-19 11:44:20
Check Details
丙通沙吉三代治疗患者SVR12较高
2025-10-19 11:44:20
Check Details
1
2
...
256
257
258
259
260
261
262
...
504
505
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Is defibrotide included in medical insurance?
2
When was defibrinoside launched on the market?
3
Will defibrination be reimbursed by medical insurance?
4
What conditions is defibrinoside suitable for treating?
5
What is the therapeutic effect of defibrotide?
6
How should defibrinoside be used?
7
What is the effect of defibrotide?
8
Defibrinoside Detailed Instructions
9
What is the effect of defibrination?
10
How effective is defibrotide in the treatment of hepatic veno-occlusive disease?
11
How effective is defibrotide in hepatic veno-occlusive disease?
12
What conditions can defibrotide treat?